Advertisement

Topics

Latest Endocrinology NewsRSS

11:14 EST 19th November 2017 | BioPortfolio

Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $3500

Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R Pipeline Review, H2 2017SummaryAccording to the recently published report 'Adrenocorticotropic Hormone Receptor Pipeline Review, H2 2017'; Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R pipeline Target constitutes close to 6 ...

Thrombotic Thrombocytopenic Purpura Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $2000

Thrombotic Thrombocytopenic Purpura Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thrombotic Thrombocytopenic Purpura Pipeline Review, H2 2017, provides an overview of the Thrombotic Thrombocytopenic Purpura Musculoskeletal Disorders pipeline landscape.Thrombotic Thrombocytopenic Purpura TTP is a rare blood disorder characteriz...

Somatostatin Receptor Type 2 SRIF1 or SSTR2 Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $3500

Somatostatin Receptor Type 2 SRIF1 or SSTR2 Pipeline Review, H2 2017SummarySomatostatin Receptor Type 2 SRIF1 or SSTR2 pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. The latest report Somatostatin Receptor Type 2 SRIF1 or SSTR2 Pipeline Review, H2 2017, outlays comprehensive infor...

Endo unit cleared of liability in first testosterone replacement trial

NEW YORK: A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim. The verdict was a victory for the drugmaker in its first trial over allegations it defectively designed Testim, a skin gel, and negligently misrepresented its risks.

Gene Therapy Could Help People Overcome Meth Addiction

Unlike opioid addiction, methamphetamine abuse disorders can’t be treated with currently available medications.

Are You Keeping An Eye On EARS And 6 Other Pharma Stocks?

If the timeline is adhered to, this clinical-stage company, focused on developing drugs for disorders concerned especially with the ear, nose, and throat, has an important catalyst coming up this quarter.

Inclusion Body Myositis IBM Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $2000

Inclusion Body Myositis IBM Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Inclusion Body Myositis IBM Pipeline Review, H2 2017, provides an overview of the Inclusion Body Myositis IBM Musculoskeletal Disorders pipeline landscape.Inclusion Body Myositis IBM is one of the inflammatory myopathies that involve inflammation of the m...

Dr. Preeti Matkins Joins Veritas Collaborative To Lead Expansion to Charlotte

Veritas' growth means more access to care for people with eating disorders Durham, NC (PRWEB) November 16, 2017 Veritas Collaborative, a specialty hospital system for the treatment of eating disorders, today announced that Dr. Preeti Matkins has joined its team as the organization prepares to expand to Charlotte, North Carolina. "Dr. Preeti Matkins is a pioneer in the eating disorders me...

Discontinuation of postmenopausal hormone therapy elevates cardiac, stroke death risk

In the first year after discontinuation of postmenopausal hormone therapy, the risk for cardiac and stroke death increases, particularly among women aged younger than 60 years, according to findings published in Menopause.“Associations between the long-term use of postmenopausal hormone therapy and risks of cardiovascular diseases have been studied for decades. The data are not uniform, perhaps ...

Sickle Cell Disease Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $2000

Sickle Cell Disease Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sickle Cell Disease Pipeline Review, H2 2017, provides an overview of the Sickle Cell Disease Hematological Disorders pipeline landscape.Sickle cell anemia is a genetic inherited blood disorder in which red blood cells, which carry oxygen around the body, develop...

Context Therapeutics Announces Senior Leadership Appointments

Strengthens team as it transitions to a clinical development stage company Advances strategy to build pipeline of novel agents for hormone-responsive cancers New executives join from Vitae Pharmaceuticals, following its successful sale to Allergan for $639 million Context Therapeutics...

Biotech Targets 'Blockbuster' Markets; Less-Addictive Opioid Painkiller Set for FDA Filing

November 16, 2017 (Investorideas.com Newswire) Medical Technology Stock Letter editor John McCamant outlines the reasons behind the buy rating and target price increases for a company that, in addition to developing an alternative to addictive opioids for pain relief, has candidates targeting multiple immune disorders and cancer.

Biotech's Target Price Increased as Shares 'Deeply Undervalued'

November 16, 2017 (Investorideas.com Newswire) Medical Technology Stock Letter editor John McCamant outlines the reasons behind the buy rating and target price increases for a company that, in addition to developing an alternative to addictive opioids for pain relief, has candidates targeting multiple immune disorders and cancer.

How Bacteria in the Gut Influence Neurodegenerative Disorders

Understanding the role of the microbiome may lead to better treatments for Parkinson's, Alzheimer's

Hormone Refractory Castration Resistant, AndrogenIndependent Prostate Cancer Global Clinical Trials Review, H2, 2017 [Report Updated: 22092017] Prices from USD $2500

Hormone Refractory Castration Resistant, AndrogenIndependent Prostate Cancer Global Clinical Trials Review, H2, 2017SummaryGlobalData's clinical trial report, Hormone Refractory Castration Resistant, AndrogenIndependent Prostate Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Hormone Refractory Castration Resistant, AndrogenIndependent Prostate Cancer clinical trials scenar...

Adrenocortical Carcinoma Adrenal Cortex Cancer Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $2000

Adrenocortical Carcinoma Adrenal Cortex Cancer Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adrenocortical Carcinoma Adrenal Cortex Cancer Pipeline Review, H2 2017, provides an overview of the Adrenocortical Carcinoma Adrenal Cortex Cancer Oncology pipeline landscape.Adrenal cortex cancer ACC is a rare disease. It is caused by...

Global Biopharma Market Research Report 20112023 [Report Updated: 06112017] Prices from USD $3610

SummaryThe global Biopharma market will reach xxx Million USD in 2017 with CAGR xx% 20182023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report describes major produ...

The viability of Anti-Müllerian Hormone (AMH) level as fertility marker

Reporter and Curator: Dr. Sudipta Saha, Ph.D.   Anti-Müllerian Hormone (AMH), is secreted by growing follicles that contains the egg or ovum. According to regular practice low AMH and high Follicle Stimulating Hormone (FSH) are generally considered as indicators of diminished egg quantity in a female. But, there are several cases the female conceived absolutely […]

TelePsy’s Platform for Blended Care

Mental healthcare comes with large societal costs and expenses are rising: increasing the societal burden. In many countries the costs have doubled over the last 10 years. Mental issues are associated with high levels of suffering and low quality of life. Effective treatments for psychological disorders are available, but not always accessible. Moreover, psychiatric complaints are still experience...

Endologix, Inc. to Present at the Piper Jaffray 29th Annual Healthcare Conference

Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that John McDermott, Chief Executive Officer, will present at the Piper Jaffray 29th Annual Healthcare Conference at 2:50 p.m. ET on Wednesday, November 29, 2017 in New York, NY. A live webcast of the presentation will be accessib...

Global Testosterone Replacement Therapy Market Data List by Segment 20152022 [Report Updated: 09112017] Prices from USD $800

SnapshotTestosterone replacement therapy TRT is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy TRT is an FDAapproved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.This report covers Testosterone Replacement Therapy basic market data by segment:1 by Produc...

Global SteroidCorticosteroids Market Data List by Segment 20152022 [Report Updated: 09112017] Prices from USD $800

SnapshotSteroidCorticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones. This report covers SteroidCorticosteroids basic market data by segment:1 by Product2 by EndUser3 by Company4 by Region5 by Channel6 by PriceThis report can also be customized according to further requirements.

Reduction in Common Heart Hormone Associated with Improved Outcomes and Lower Mortality for Heart Failure Patients

Heart failure patients discharged from the hospital with a reduced level of a common hormone produced by the heart had significantly lower rates of readmission and lower death rates.

Hormone Replacement: Have We Made Progress Since WHI?

Vaginal estrogen may improve vaginal symptoms of menopause and does not increase the risk for endometrial cancer, stroke, or cardiovascular disease.

Both Obese and Anorexic Women Suffer Low Levels of Mood-Enhancing Hormone

Studies by researchers in the U.S. suggest that a metabolite of progesterone may represent a new therapeutic target for depression and anxiety in otherwise treatment-resistant groups of patients, including those with anorexia nervosa. Collaborating scientists at Massachusetts General Hospital, the University of Illinois at Chicago, and Boston University School of Medicine found low levels of the n...

Quick Search
Advertisement
 

review and buy Endocrinology market research data and corporate reports here